Recent advances in the systemic treatment of metastatic papillary renal cancer. - Wikidata - awgldk - TriplyDB

Recent advances in the systemic treatment of metastatic papillary renal cancer.

Recent advances in the systemic treatment of metastatic papillary renal cancer.

http://www.wikidata.org/entity/Q37411186

about

Imaging management of incidentally detected small renal masses.Retrospective survival analysis of 237 consecutive patients with multiple pulmonary metastases from advanced renal cell carcinoma exclusively resected by a 1318-nm laser.Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.Environmental-mediated drug resistance: a target for multiple myeloma therapy.Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells High temporal resolution 3D gadolinium-enhanced dynamic MR imaging of renal tumors with pharmacokinetic modeling: preliminary observations.Chemical shift magnetic resonance imaging for distinguishing minimal-fat renal angiomyolipoma from renal cell carcinoma: a meta-analysis.

P2860

Q26862876-16DFAE06-4BEC-40E2-A87A-A257032D6FAF Q35632452-0DB670F6-360C-470A-B248-37ADC935AA20 Q36014320-D67F848E-539B-4E57-A293-154ECBFADA46 Q37810085-00755BC4-529C-4333-93DC-6BCAB5C63CCF Q39048858-95B2BF43-C167-49BA-88FC-56FE3F682E2A Q45968202-D0BFB56E-589C-4653-82E5-9164AE6EFA24 Q47409981-54D86FAD-72A6-4C5B-B09E-0F6417A2851A

P2860

Recent advances in the systemic treatment of metastatic papillary renal cancer.

http://www.wikidata.org/entity/Q37411186

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Recent advances in the systemic treatment of metastatic papillary renal cancer.

@en

Recent advances in the systemic treatment of metastatic papillary renal cancer.

@nl

type

label

Recent advances in the systemic treatment of metastatic papillary renal cancer.

@en

Recent advances in the systemic treatment of metastatic papillary renal cancer.

@nl

prefLabel

Recent advances in the systemic treatment of metastatic papillary renal cancer.

@en

Recent advances in the systemic treatment of metastatic papillary renal cancer.

@nl

P1433

Q37411186-682ED11D-F3E8-406B-8EB8-61784FCA70BF

P1476

Q37411186-49C3FE9B-7FA1-4C65-9BDA-15E0202E0C96

P2093

Q37411186-0FED8E1B-E4B0-4629-AC80-55A2BB5DE909

Q37411186-5572E918-942C-4105-9F5D-4606352F669D

P2860

Q37411186-0F82755D-243C-4D6D-9BBD-D39C915F43CA

Q37411186-161437D1-04CE-47EC-8AC2-66AEBAD2FC8D

Q37411186-194B721E-6FA4-4323-A663-734C0DA9C902

Q37411186-197FED88-CB2D-4E0D-9CAD-353F823F690E

Q37411186-1C2BAF09-990E-4C48-BCC1-3CC121C5A953

Q37411186-246F8CE0-365E-483D-94FF-6449AF589904

Q37411186-2E6F044B-943D-49C3-AD76-D2D2448A602F

Q37411186-3AF0BCE3-9B59-4459-AE51-D2228D9167AC

Q37411186-3DE7E02B-BD7D-4C66-900E-2BDD2FCA0C3F

Q37411186-3FA9B95B-F7E9-461A-9E4C-098DEFE6D5EF

P304

Q37411186-6A14C250-0C12-431E-8D98-9FAA522F6E6C

P31

Q37411186-DA71391D-2EE0-40A1-9B99-8151EA5C6728

P356

Q37411186-B3BA3BDE-4A21-4219-BB51-548A9DA736AC

P433

Q37411186-37C8F54F-7F30-4207-BE49-4DC1638BB388

P478

Q37411186-B9CE877D-EC7F-48CC-91D5-75672A23976E

P577

Q37411186-9ADF7A83-73BE-43ED-9027-935BB9951E49

P698

Q37411186-9DB9495C-FE70-4C08-B4FF-5AFE7FB536CD

P356

14737140.9.3.373

P1433

Expert Review of Anticancer Therapy

P1476

Recent advances in the systemic treatment of metastatic papillary renal cancer.

@en

P2093

Simon Chowdhury

http://www.w3.org/2001/XMLSchema#string

Toni K Choueiri

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

Cell signaling by receptor tyrosine kinases

Cancer statistics, 2008

Raf kinase as a target for anticancer therapeutics

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Sorafenib in advanced clear-cell renal-cell carcinoma

Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

P304

373-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.9.3.373

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19275514

http://www.w3.org/2001/XMLSchema#string